Nadeem SarwarVP & Head, Genetics & Human Biology Eisai
Kiran ReddyAssociate Partner Third Rock Ventures
Gabriel VargasExecutive Medical Director Amgen
Dario DollerDirector, Discovery Chemistry & DMPK Lundbeck
23 speakers. 26 sessions. 1 CNS Leader's Forum. 5 Interactive Sessions. 10 hours of Networking. World CNS 2015 is here.
This year the agenda has been put together to focus on providing you with the key information to improve the predictive validity of your preclinical models and biomarkers.
Designed to build on the collaboration of previous years and drive the forward movement for the industry, leading drug developers such as Pfizer, Amgen, Eisai and Abbvie will be here, sharing their honest insights and experiences. Attend and you will discover how you can strengthen CNS drug development and gain practical advice on how to ultimately de-risk your clinical trials.
Here's a snapshot of what you will learn:
“Great organization, agenda, speaker panel, audience – I couldn’t have asked for anything more!” Scannexus
“The conference was an excellent size where optimal discussion occurredand the presentations were of high quality” Envivo Pharma
“ Overall an excellent meeting. Thanks.” AMRI
“The speakers tried to emphasize specific strategies to overcome shortcomings in recent drug development history. This differentiates the summit.” Partner HealthCare